Trial Profile
An open-label pilot study of high-concentration capsaicin patches in treatment of painful HIV-associated neuropathy
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Capsaicin (Primary)
- Indications Neuropathic pain
- Focus Therapeutic Use
- 16 Oct 2005 New trial record.